Santen Pharmaceutical Co (MEX:4536N) Market Cap: MXN67,925 Mil (As of Aug. 13, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MEX:4536N Santen Pharmaceutical Co Ltd MEX:4536N
88 GF Score
Price MXN339.23
GF Value MXN296.23
View Full Analysis

What is Santen Pharmaceutical Co Market Cap?

Santen Pharmaceutical Co MEX:4536N 88 Market Cap is MXN67,925 Mil as of Aug. 13, 2026. GuruFocus rates MEX:4536N with a GF Score™ of 88/100 and a GF Value™ of MXN296.23. Among 1,022 Drug Manufacturers companies, Santen Pharmaceutical Co ranks better than 90.7% on this metric.

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Santen Pharmaceutical Co's share price for the quarter that ended in Jun. 2026 was MXN339.23. Santen Pharmaceutical Co's Shares Outstanding (EOP) for the quarter that ended in Jun. 2026 was 322 Mil. Therefore, Santen Pharmaceutical Co's market cap for the quarter that ended in Jun. 2026 was MXN109,126 Mil.

Santen Pharmaceutical Co's quarterly market cap increased from Dec. 2025 (MXN109,121 Mil) to Mar. 2026 (MXN109,123 Mil) and increased from Mar. 2026 (MXN109,123 Mil) to Jun. 2026 (MXN109,126 Mil).

Santen Pharmaceutical Co's annual market cap declined from Mar. 2024 (MXN123,211 Mil) to Mar. 2025 (MXN115,801 Mil) and declined from Mar. 2025 (MXN115,801 Mil) to Mar. 2026 (MXN109,123 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Santen Pharmaceutical Co's Enterprise Value for Today is MXN59,079 Mil.


Santen Pharmaceutical Co  (MEX:4536N) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Santen Pharmaceutical Co Market Cap Related Terms


Santen Pharmaceutical Co Market Cap Historical Data

* Premium members only.

The historical data trend for Santen Pharmaceutical Co's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Santen Pharmaceutical Co Market Cap Chart

Santen Pharmaceutical Co Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Market Cap
Get a 7-Day Free Trial Premium Member Only Premium Member Only 135,783.93 127,394.77 123,211.39 115,800.91 109,123.17

Santen Pharmaceutical Co Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 114,135.97 110,193.44 109,120.79 109,123.17 109,125.88

MEX:4536N vs LLY, JNJ, ABBV: Market Cap Comparison

For the Drug Manufacturers - General subindustry, Santen Pharmaceutical Co's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Santen Pharmaceutical Co Market Cap vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Santen Pharmaceutical Co's Market Cap distribution charts can be found below:

* The bar in red indicates where Santen Pharmaceutical Co's Market Cap falls into.


MEX:4536N
88GF Score
Santen Pharmaceutical Co Ltd MEX:4536N
Market Cap is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Santen Pharmaceutical Co Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Santen Pharmaceutical Co's Market Cap for the fiscal year that ended in Mar. 2026 is calculated as

Market Cap (A: Mar. 2026 )=Share Price (A: Mar. 2026 )*Shares Outstanding (EOP) (A: Mar. 2026 )
=MXN339.23*321.679
=MXN109,123

Santen Pharmaceutical Co's Market Cap for the quarter that ended in Jun. 2026 is calculated as

Market Cap (Q: Jun. 2026 )=Share Price (Q: Jun. 2026 )*Shares Outstanding (EOP) (Q: Jun. 2026 )
=MXN339.23*321.687
=MXN109,126

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Market Cap →
What does a Market Cap of MXN67,925 Mil mean?
Santen Pharmaceutical Co (MEX:4536N) has a Market Cap of MXN67,925 Mil as of Aug. 13, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Santen Pharmaceutical Co and its competitors. According to the industry distribution chart, Santen Pharmaceutical Co ranks #95 out of 1022 companies in the Drug Manufacturers industry, placing it in the top 9.3%.
Is Santen Pharmaceutical Co's Market Cap too high?
Santen Pharmaceutical Co's current Market Cap is MXN67,925 Mil. Based on the distribution chart, Santen Pharmaceutical Co ranks #95 out of 1022 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Santen Pharmaceutical Co has a GF Score™ of 88/100, reflecting its overall financial health beyond just this single metric.
How does Santen Pharmaceutical Co's Market Cap compare to LLY and JNJ?
According to the Drug Manufacturers industry distribution chart, Santen Pharmaceutical Co ranks #95 out of 1022 companies for Market Cap. This places Santen Pharmaceutical Co in the top 9% of its industry — outperforming the majority of peers. The industry median Market Cap is 231.08. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Drug Manufacturers company?
The median Market Cap among Drug Manufacturers companies is 231.08, based on 1,022 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Santen Pharmaceutical Co and its competitors. For the Drug Manufacturers industry, the median Market Cap is 231.08 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Santen Pharmaceutical Co's current Market Cap is MXN67,925 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Santen Pharmaceutical Co stock overvalued right now?
Santen Pharmaceutical Co (MEX:4536N) has a current Market Cap of MXN67,925 Mil. The stock's GF Value™ is MXN296.23, compared to a current price of MXN339.23 — trading 14.5% above its estimated fair value. The current Market Cap is MXN67,925 Mil. Santen Pharmaceutical Co's overall GF Score™ is 88/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Santen Pharmaceutical Co (MEX:4536N), the current Market Cap is MXN67,925 Mil as of Aug. 13, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Santen Pharmaceutical Co (MEX:4536N) Overvalued in 2026?

Based on GuruFocus' analysis, Santen Pharmaceutical Co stock appears to be overvalued. The current stock price of MXN339.23 is trading 14.5% above its estimated GF Value™ of MXN296.23.

Key valuation signals for MEX:4536N:

  • Market Cap: MXN67,925 Mil
  • GF Value™: MXN296.23 vs. price of MXN339.23 (14.5% above fair value)
  • GF Score™: 88/100

No single metric tells the full story. See the MEX:4536N stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Santen Pharmaceutical Co Business Description

Other Exchanges SNPHY:USA4536:Japan
Address 4-20 Ofukacho, Grand Front Osaka Tower A, Kita-ku, Osaka Prefecture, Osaka, JPN, 530-8552
Santen Pharmaceutical Co Ltd is a drug manufacturing company that focuses on ophthalmic products. The company provides a wide range of prescription and over-the-counter eye care products, including treatments for glaucoma, dry eye, and allergies. It also develops surgical and diagnostic devices related to eye care.
88GF Score

Get the complete analysis for MEX:4536N

Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN339.23
Price
MXN296.23
GF Value